A Dual-Channel Electrochemical Biosensor Enables Concurrent Detection of Pathogens and Antibiotic Resistance

Dharanivasan Gunasekaran,Irina Rostovsky,David Taussig,Talya Bar-Am,Yariv Wine,Neta Sal-Man,Sefi Vernick
DOI: https://doi.org/10.1016/j.bios.2024.116314
IF: 12.545
2024-04-22
Biosensors and Bioelectronics
Abstract:Diarrhoeagenic E. coli infections, commonly treated with β-lactam antibiotics, contribute to antibiotic resistance - a pressing public health concern. Rapid monitoring of pathogen antibiotic resistance is vital to combat antimicrobial spread. Current bacterial diagnosis methods identify pathogens or determine antibiotic resistance separately, necessitating multiple assays. There is an urgent need for tools that simultaneously identify infectious agents and their antibiotic resistance at the point of care (POC). We developed an integrated electrochemical chip-based biosensor for detecting enteropathogenic E. coli (EPEC), a major neonatal diarrheal pathogen, using an antibody against a virulence marker, termed EspB, and the β-lactam resistance marker, β-lactamase. A dual-channel microfabricated chip, bio-functionalized with a specific EspB monoclonal antibody, and nitrocefin, a β -lactamase substrate was utilized. The chip facilitated electrochemical impedance spectroscopy (EIS)-based detection of EspB antigen and EspB-expressing bacteria. For β-lactam resistance profiling, a second channel enabled differential-pulse voltammetric (DPV) measurement of hydrolyzed nitrocefin. EIS-based detection of EspB antigen was calibrated (LOD: 4.3 ng/mL ±1 and LOQ: 13.0 ng/mL ±3) as well as DPV-based detection of the antibiotic resistance marker, β-lactamase (LOD: 3.6 ng/mL ±1.65 and LOQ: 10 ng/mL ±4). The integrated EIS and DPV biosensor was employed for the simultaneous detection of EspB-expressing and β-lactamase-producing bacteria. The combined readout from both channels allowed the distinction between antibiotic-resistant and -sensitive pathogenic bacteria. The integrated electrochemical biosensor successfully achieved simultaneous, rapid detection of double positive EspB- and β-lactamase-expressing bacteria. Such distinction enabled by a portable device within a short assay time and a simplified sample preparation, may be highly valuable in mitigating the spread of AMR. This new diagnostic tool holds promise for the development of POC devices in clinical diagnosis.
biotechnology & applied microbiology,biophysics,chemistry, analytical,electrochemistry,nanoscience & nanotechnology
What problem does this paper attempt to address?
The problem this paper attempts to address is that current bacterial diagnostic methods typically identify pathogens or determine antibiotic resistance separately, requiring multiple tests. Therefore, there is an urgent need for a tool that can simultaneously identify infectious agents and their antibiotic resistance at the point of care (POC). Specifically, this study developed a chip-based dual-channel electrochemical biosensor for the simultaneous detection of enteropathogenic Escherichia coli (EPEC) and its β-lactamase resistance. ### Main Issues 1. **Necessity of Multiple Tests**: Current bacterial diagnostic methods usually require multiple separate tests to identify pathogens and determine their antibiotic resistance, which is both time-consuming and expensive. 2. **Need for Point-of-Care Diagnosis**: Rapid and accurate detection and identification of resistant pathogens at the point of care are crucial for clinical decision-making and reducing antibiotic misuse. ### Solution This study developed an integrated dual-channel electrochemical biosensor capable of simultaneously detecting: - **EPEC virulence factor EspB**: Immuno-impedance measurement using monoclonal antibodies against EspB. - **β-lactamase resistance**: Differential pulse voltammetry (DPV) measurement of hydrolysis products of nitrocefin. ### Key Technologies 1. **Dual-channel Microfabricated Chip**: One channel for detecting EspB antigen and the other for detecting β-lactamase activity. 2. **Immuno-impedance Measurement**: Detection of EspB antigen and EspB-expressing bacteria using electrochemical impedance spectroscopy (EIS). 3. **Differential Pulse Voltammetry**: Assessment of β-lactamase activity by detecting hydrolysis products of nitrocefin. ### Advantages - **High Sensitivity**: The limit of detection (LOD) for EIS detection of EspB antigen is 4.3 ng/mL, and the limit of quantification (LOQ) is 13.0 ng/mL; the LOD for DPV detection of β-lactamase is 3.6 ng/mL, and the LOQ is 10 ng/mL. - **Rapid Detection**: Capable of completing detection in a short time, simplifying the sample processing procedure. - **Portability**: Suitable for point-of-care devices, helping to reduce the spread of antibiotic resistance. ### Conclusion This novel diagnostic tool has great potential in clinical diagnostics, enabling rapid and accurate simultaneous detection of EPEC and its β-lactamase resistance, which helps reduce antibiotic misuse and positively impacts the spread of antibiotic resistance.